[Inflamed dermatoses. Treatment with Bufexamac. A randomized comparative double-blind study against fluocortinbutyl ester].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002019:Bufexamac / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy*; D004311:Double-Blind Method; D005448:Fluocortolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D008875:Middle Aged; D011897:Random Allocation
D006877:Hydroxamic Acids; D002019:Bufexamac; D005448:Fluocortolone; C011824:fluocortin butyl ester
Entzündliche Dermatosen. Behandlung mit Bufexamac. Eine randomisierte vergleichende Doppelblindstudie gegen fluocortinbutylester.